Rxo Inc (NYSE:RXO) Receives $17.93 Average Price Target from Analysts

Key Points

• Rxo Inc (NYSE:RXO) has received a consensus rating of "Hold" from analysts, with one sell, twelve hold, and three buy recommendations.
• The average 12-month target price for RXO shares is $17.93, with recent price adjustments by analysts reflecting a range of $12.00 to $18.00.
• RXO's latest earnings report showed earnings of $0.04 EPS and revenue of $1.42 billion, indicating a 52.6% year-over-year revenue growth.

Shares of Rxo Inc (NYSE:RXO - Get Free Report) have earned a consensus recommendation of "Hold" from the sixteen research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $16.9231.

RXO has been the subject of a number of recent research reports. Barclays lowered their target price on RXO from $18.00 to $17.00 and set an "overweight" rating for the company in a report on Tuesday, August 12th. UBS Group reaffirmed a "neutral" rating and issued a $15.00 target price (up previously from $14.00) on shares of RXO in a report on Friday, August 8th. Cowen reaffirmed a "hold" rating on shares of RXO in a report on Friday, August 8th. JPMorgan Chase & Co. lowered their target price on RXO from $15.00 to $14.00 and set an "underweight" rating for the company in a report on Tuesday, July 8th. Finally, Wall Street Zen raised RXO from a "sell" rating to a "hold" rating in a report on Saturday, August 9th.

RXO Price Performance

Shares of RXO stock traded down $0.54 during trading on Friday, reaching $16.94. 2,111,239 shares of the company's stock were exchanged, compared to its average volume of 1,860,156. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.35 and a current ratio of 1.35. RXO has a 1-year low of $12.19 and a 1-year high of $31.98. The company has a market cap of $2.78 billion, a P/E ratio of -7.84, a PEG ratio of 8.34 and a beta of 1.69. The firm's 50-day moving average price is $16.11 and its 200 day moving average price is $16.11.

RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. RXO had a positive return on equity of 1.18% and a negative net margin of 5.45%.The company had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.44 billion. During the same quarter in the previous year, the firm earned $0.03 EPS. RXO's revenue was up 52.6% on a year-over-year basis. As a group, research analysts anticipate that RXO will post 0.31 earnings per share for the current year.

Institutional Investors Weigh In On RXO

Several institutional investors and hedge funds have recently made changes to their positions in RXO. AlphaQuest LLC acquired a new stake in shares of RXO in the second quarter valued at about $29,000. Geneos Wealth Management Inc. acquired a new stake in shares of RXO in the first quarter valued at about $30,000. Larson Financial Group LLC increased its stake in shares of RXO by 1,990.2% in the first quarter. Larson Financial Group LLC now owns 1,714 shares of the company's stock valued at $33,000 after buying an additional 1,632 shares during the period. CWM LLC increased its stake in shares of RXO by 234.4% in the first quarter. CWM LLC now owns 1,876 shares of the company's stock valued at $36,000 after buying an additional 1,315 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of RXO by 52.5% in the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,745 shares of the company's stock valued at $52,000 after buying an additional 945 shares during the period. Institutional investors and hedge funds own 92.73% of the company's stock.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.